30-year journey from the start of the Human Genome Project to clinical application of genomics in psychiatry: are we there yet?

Lancet Psychiatry. 2020 Jan;7(1):7-9. doi: 10.1016/S2215-0366(19)30477-8.

Authors

Nina Roth Mota¹, Barbara Franke²

Affiliations

¹ Department of Human Genetics and Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen 6500 HB, Netherlands.
² Department of Human Genetics and Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen 6500 HB, Netherlands. Electronic address: barbara.franke@radboudumc.nl.

PMID: 31860458
DOI: 10.1016/S2215-0366(19)30477-8

No abstract available

MeSH terms

Antipsychotic Agents / adverse effects
Antipsychotic Agents / therapeutic use
Genomics / trends*
Human Genome Project / organization & administration*
Humans
Mental Disorders* / drug therapy
Mental Disorders* / genetics
Obesity
Olanzapine / adverse effects
Olanzapine / therapeutic use
Psychiatry*
Weight Gain

Substances

Antipsychotic Agents
Olanzapine